Clinical trials: Biliary Cancer Metastatic

Biliary Tract Cancer

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

• Completed
• Age: All ages
• Phase 2/3
• Results posted

This protocol for Varlitinib is developed for the treatment of Biliary Tract Cancer. Varlitinib (also known as ASLAN001) is a small-molecule, adenosine triphosphate competitive inhibitor of the tyrosine kinases - epidermal growth…

Trial name

TreeTopp (NCT03093870)

Testing

Varlitinib, Capecitabine

Where

21 sites in United States, Australia and 9 more

Volunteers

151 people

Sponsor

ASLAN Pharmaceuticals